Table S1. Univariate and multivariate analysis for seroconversion using binary logistic regression in the 705 patients who were seronegative immediately before the fourth dose.
Univariate analysis Multivariate analysis
Factors P OR (95% CI) P OR (95% CI)
Age at fourth dose 0.010 0.95 (0.92–0.99) 0.031 0.96 (0.93–0.99)
Male gender 0.441 1.17 (0.79–1.73) -
Diabetes mellitus 1.000 1.10 (0.52–2.36) -
Time from transplantation to fourth dose 0.131 1.04 (0.99–1.09) -
Deceased donor (vs living donor) 0.002 0.33 (0.17–0.66) 0.005 0.36 (0.18–0.73)
Tacrolimus (vs cyclosporine) 0.636 0.84 (0.38–1.83) -
Mycophenolate (vs AZA/mTORi, in patients on calcineurin inhibitors) 0.447 0.89 (0.69–1.16) - mTORi (vs AZA/MPA, in patients on calcineurin inhibitors) 0.666 0.83 (0.42–1.64)
Time from third to fourth dose 0.426 0.99 (0.97–1.01) -
AZA, azathioprine; CI, confidence interval; MPA, mycophenolic acid; mTORi, inhibitor of the mammalian target of rapamycin; OR, odds ratio.